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Bright Green Biofluorescence in Sharks
Derives from Bromo-Kynurenine Metabolism
Hyun Bong Park,1,2 Yick Chong Lam,1,2 Jean P. Gaffney,3,4 James C. Weaver,5 Sara Rose Krivoshik,3,4
Randy Hamchand,1,2 Vincent Pieribone,6 David F. Gruber,3,4,* and Jason M. Crawford1,2,7,8,*
SUMMARY
Although in recent years there has been an increased awareness of the widespread nature of biofluorescence in the marine environment, the diversity of the molecules responsible for this luminescent
phenotype has been mostly limited to green fluorescent proteins (GFPs), GFP-like proteins, and fluorescent fatty acid-binding proteins (FABPs). In the present study, we describe a previously undescribed
group of brominated tryptophan-kynurenine small molecule metabolites responsible for the green biofluorescence in two species of sharks and provide their structural, antimicrobial, and spectral characterization. Multi-scale fluorescence microscopy studies guided the discovery of metabolites that were
differentially produced in fluorescent versus non-fluorescent skin, as well as the species-specific structural details of their unusual light-guiding denticles. Overall, this study provides the detailed description
of a family of small molecules responsible for marine biofluorescence and opens new questions related to
their roles in central nervous system signaling, resilience to microbial infections, and photoprotection.

INTRODUCTION
Biofluorescence is a widespread phenomenon in the marine environment, which results from the absorbance of the dominant ambient blue ocean light and its re-emittance at longer, lower-energy wavelengths,
visually resulting in green, orange, and red fluorescence. Following the seminal 1962 discovery of green
fluorescent protein (GFP) from Aequorea victoria, a hydrozoan medusa (Shimomura et al., 1962), fluorescent proteins (FPs) have since been described from cnidarians (Gruber et al., 2008; Matz et al., 1999), crustaceans (Meyers et al., 2004), and cephalochordates (Deheyn et al., 2007). The discovery of GFP has led to
numerous breakthroughs in biomedical science (Gruber and Pieribone, 2006) following the exhibition of its
heterologous expression (Chalfie et al., 1994) and mutations that led to brighter and spectrally modulatable variants (Tsien, 1998). GFP-like fluorescent proteins have since been identified in a wide range of other
cnidarians, including corals, anemones, hydroids, pennatulids, and corallimorpharians and are now recognized as a ubiquitous metazoan protein superfamily (Shagin et al., 2004).
Within fishes, biofluorescence was only recently reported to be a phylogenetically widespread and phenotypically variable phenomenon that encompasses at least 16 orders, 50 families, 105 genera, and over 180 species
(Sparks et al., 2014). Yet among this multitude of biofluorescent fish species, the chemistry had only been elucidated in the eels, Anguilla japonica (Hayashi and Toda, 2009; Kumagai et al., 2013), Kaupichthys hyoproroides,
and Kaupichthys n. sp (Gruber et al., 2015), all of which are bilirubin-inducible fluorescent proteins. Here, we focus
on the chemical mechanism of biofluorescence in two species of elasmobranchs, both in the family Scyliorhinidae, with Cephaloscyllium ventriosum (the swell shark) being endemic to the eastern Pacific (Compagno, 1984)
and Scyliorhinus retifer (the chain catshark) from the western Atlantic (Castro, 2011).
Regional biofluorescence of the skin of these sharks has previously been shown to exhibit a higher intensity
of the green-dominated fluorescence in the lighter, beige-colored areas, compared with the darker reticulated lines for the chain catshark or the dark spots for the swell shark (Figure 1) (Gruber et al., 2016).
Through comparative metabolic profiling studies between these two distinctly pigmented tissue types,
we report the discovery of a suite of small molecule metabolites stimulated in the light skin tissue, relative
to the dark skin tissue from these two shark species. Specifically, high-resolution mass spectrometry (MS),
UV-visible spectroscopy, multidimensional nuclear magnetic resonance (NMR), and fluorescence spectroscopy were used to unambiguously identify and characterize a family of brominated tryptophan-kynurenine
metabolic products that are responsible for the biofluorescence phenotype in these two species of shark.
Although GFP, GFP-like proteins, and bilirubin-binding fluorescent proteins have been reported from a variety of invertebrate (Gruber et al., 2008; Matz et al., 1999) and vertebrate (Gruber et al., 2015; Hayashi and
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Figure 1. Fluorescent Shark Imaging
(A–H) Bright-field and fluorescence imaging of Scyliorhinus retifer (A–C) and Cephaloscyllium ventriosum (D–F). In
contrast to the dark denticles from C. ventriosum, those from S. retifer act as efficient optical waveguides, effectively
channeling the fluorescence signal along their length. S. retifer has a second type of larger, non-light-guiding denticles (G
and H), and bright-field (left) and fluorescence (right) imaging reveals that the larger non-light-guiding denticles can easily
be distinguished through bright-field imaging (due to their ability to weakly scatter blue light from their longitudinal
surface ridges). A patch of both denticle types is shown in (G), whereas the larger non-light-guiding denticles are
highlighted with asterisks in (H). Image widths: B, 20 mm; C, 1.2 mm; E, 20 mm; F, 1.5 mm; G, 7 mm; H, 3.3 mm.

Toda, 2009; Kumagai et al., 2013) taxa, these brominated tryptophan-kynurenine metabolites from elasmobranchs represent a previously undescribed family of biofluorescent small molecule metabolites.

RESULTS
Skin Tissue Structure in Microscopy
C. ventriosum has small intensely green fluorescent spots over much of the body (Video S1), which appear light
beige under white light. S. retifer, in contrast, exhibits an alternating light and dark reticulated pigmentation
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pattern, but it lacks the brightly fluorescent spots characteristic of C. ventriosum (Figure 1). Excised skin pieces
from C. ventriosum and S. retifer were examined in their native state using a dual-camera Zeiss Axio zoom v16
fluorescence microscope. For sequential data collection from identical areas, the bright-field images were
acquired with a Zeiss 506 color digital camera and the green fluorescence images were acquired with a
Hamamatsu Flash 4.0 black and white digital camera. We note a surprising finding that the dermal denticles
of C. ventriosum are not fluorescent, whereas those of S. retifer act as efficient optical waveguides, channeling
the fluorescent signal along their length (Figure 1). Further analysis of S. retifer denticle structural diversity revealed that in addition to the smaller light-guiding denticles, a second type of larger, non-light-guiding denticles are also present (Figures 1G and 1H). This shows that the green fluorescence is not only targeted to varying
regions of the shark but also that the targeting is fine-tuned to specific denticle types within a shark species. It
has been previously demonstrated that these shark species possess the visual apparatus to detect biofluorescence (484 and 488-nm monochromat visual pigments in C. ventriosum and S. retifer, respectively)
and that there are pronounced sexually dimorphic fluorescent patterns (Gruber et al., 2016). The green biofluorescence thus creates greater visual contrast for these sharks at depth, due to the primarily blue mesophotic
marine environment (Gruber et al., 2016). It has also been shown that there are species-specific emission patterns in other fluorescent fish species, leading to the suggestion that biofluorescence functions in intraspecific
communication and assists camouflage (Sparks et al., 2014). These observations of biofluorescent targeting to
specific denticle types further advances our understanding of the complexity of this unique biofluorescence in
the shark skin and the possible optical functions it may play. It is also noteworthy, that the deep-sea lanternshark
(Etmopterus spinax) has also been shown to utilize its mineralized spines for the transmission of bioluminescent
signals (Claes et al., 2013).

Brominated Metabolites in Swell Shark Skin Tissue
To establish a molecular basis for shark skin biofluorescence, we first analyzed small molecule extracts of dark
and light skin tissue samples from the swell shark (C. ventriosum). Skin tissues were dissected using a fluorescence microscope (Zeiss-Axio Zoom V16 stereo fluorescent microscope) affixed with a Nikon D4 camera. The
organic crude extracts of skin tissue samples were analyzed using an ultrahigh-performance liquid chromatography (UPLC) system equipped with a photodiode array detector and a high-resolution electrospray ionizationquadrupole time-of-flight-mass spectrometer (HR-ESI-QTOF-MS) (Figures 2A and S1). We first analyzed two
major metabolites 4 and 5 eluting at retention times 19.2 and 11.2 min, respectively, which were similarly present
in both the dark and light tissue samples (Figures 2A and S2). Their high-resolution mass spectra in positive
mode showed an isotope distribution pattern attributable to the presence of bromine atoms at m/z
528.9875, 530.9859, and 532.9843 (relative intensity 1:2:1) for 4 and at m/z 283.0109 and 285.0090 (relative intensity 1:1) for 5, indicating the molecular formulas of 4 and 5 to be C22H18Br2N4O2 and C11H11BrN2O2, respectively
(Table S1 and Figure S1). In addition, UV-visible spectra of these peaks shared a characteristic indole chromophore, suggesting the presence of a brominated tryptophan moiety known to be fluorescent (Figures S7A and
S8A) (Schnepel et al., 2016). The chemical structures of these metabolites isolated from swell shark skin were fully
elucidated using 1H and gradient-enhanced 2D NMR (correlation spectroscopy, heteronuclear single-quantum
coherence with adiabatic pulses, and heteronuclear multiple-bond correlation with adiabatic pulses) and Marfey’s analysis (Figures S7, S8, S15, and S16, and Table S3). The NMR interpretation of these metabolites revealed
resonances and correlations attributable to a 6-bromo tryptophan-derived diketopiperazine (4) and its monomer substrate (5), respectively (Figure 2B). Marfey’s analysis on 4 and 5 allowed us to establish their structures as
(9S, 90 R)-6-bromo-tryptophan-derived diketopiperazine and 9S-bromo-tryptophan, respectively (Figures S7C
and S8C).
We then focused on small molecules differentially produced in light and dark skin tissue samples. We detected five major metabolites (1–3, 7, and 8) that were significantly stimulated in the light samples relative
to the dark samples (Figure 2A). The UV-visible spectrum of metabolite 1 was similar to that of kynurenine
(Figure S4A), a major product of tryptophan catabolism in mammals (Cervenka et al., 2017; Kolodziej et al.,
2011). However, the HR-ESI-QTOF-MS data of 1 (m/z 287.0032 and 289.0013 [relative intensity 1:1]) similarly
supported the presence of a bromine atom in its chemical formula (C10H11BrN2O3) (Figure S1 and Table
S1), suggesting that the structure of 1 could be a bromo-kynurenine. The chemical formulas of 2, 3, 7,
and 8 were deduced as C11H11BrN2O4, C10H9BrNO3, C7H6BrNO2, and C10H9BrNO3, respectively, and
UV-visible spectroscopic data suggested that they were additional brominated metabolites processed
through the kynurenine pathway: N-formyl-bromo-kynurenine (2), bromo-CKA (carboxyketoalkene derivative of kynurenine) (3), bromo-anthranilic acid (7), and bromo-kynurenine yellow (8) Figures 2B, S5A, S6A,
S10A, and S11A and Table S1).
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Figure 2. Comparative Metabolic Profiles of Skin Extracts from Cephaloscyllium ventriosum
(A) Differential extracted ion counts chromatograms corresponding to eight representative metabolites from light and dark areas of skin.
(B) Chemical structures of metabolites 1–8. 1–4 and 8 represent previously unknown metabolites.

The structural characterization of metabolites 1–3 was achieved through chemical synthesis (Figures S3A
and S12–S14, and Table S2). Briefly, a substrate, 6-bromo-L-tryptophan (5), was prepared and metachloroperoxybenzoic acid (0.32 g, 1.854 mmol, 10.5 equiv.) was added. The chemical reaction was stirred
at room temperature under air atmosphere for 20 h to yield the 8-bromo-N-formyl-L-kynurenine (2). Deformylation with 50% trifluoroacetic acid (TFA) led to the product 8-bromo-L-kynurenine (1), which was
deaminated under 70 C to give the 8-bromo-CKA (3) (Figure S3A). Co-injection and Marfey’s analysis
with synthetic and natural materials unambiguously confirmed the absolute chemical structures of these
metabolites (Figures S4–S6). The structure of 7 was determined as 4-bromo-anthranilic acid by comparison of UV spectra and liquid chromatography (LC)-MS co-injection with a commercial standard (Figure S10). Last, we chemically synthesized compound 8 employing a synthetic scheme analogous to a
previous report (Higgins et al., 2009) (Figures S3B, S17, and S18 and Table S4), and co-injection studies
with the synthetic standard and the natural skin material confirmed the proposed structure of 8
(Figure S11).

Brominated Metabolites in Chain Catshark Skin Tissue
We next examined whether these metabolites existed in the biofluorescent chain catshark, S. retifer.
Comparative metabolic analysis revealed that the same brominated metabolites are also present in chain
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Figure 3. Comparative Metabolic Analysis of Skin Extracts from Cephaloscyllium ventriosum (Swell Shark) and
Scyliorhinus rotifer (Chain Catshark)

catsharks (Figure 3), although metabolite 3 was below the detection limit under the conditions of our
experiments. In addition, we identified major metabolite 6, a brominated variant of indole-3-glyoxylic
acid in S. retifer and confirmed its structure by co-injection experiments with an authentic standard (Figure S9). These studies identified a total of eight small molecule metabolites from biofluorescent shark
skins.

Kynurenine Metabolism
The structures of the brominated metabolites in biofluorescent shark skins suggest that the brominated
tryptophan found in both dark and light skin tissues is promiscuously processed through the tryptophan-kynurenine pathway (Figure 4). In humans, kynurenine metabolism is known to regulate important
biological processes, including host-microbiome signaling and immune response, and is also linked to
the pathogenesis of a variety of diseases such as diabetes, inflammation, neurodegenerative disorders,
and cancer (Cervenka et al., 2017; Mazarei and Leavitt, 2015; Van der Leek et al., 2017). As enzymes involved
in kynurenine metabolism can also be found in diverse bacteria (Bortolotti et al., 2016; Forouhar et al., 2007;
Kurnasov et al., 2003), we tested if the common gut inhabitant E. coli is capable of metabolizing 6-bromo-Ltryptophan to 8-bromo-L-kynurenine. Indeed, E. coli Nissle 1917 biotransformed 6-bromo-L-tryptophan to
8-bromo-L-kynurenine in the ratio of 64:1, as determined by LC-MS (Figure S19), further supporting flexibility in functionalized tryptophan catabolism.
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Figure 4. Overview of the Kynurenine and Bromo-kynurenine Pathway
Bromo-tryptophan appears to be promiscuously processed through the kynurenine pathway to generate the
biofluorescent shark metabolites.

Absorbance and Fluorescence Emission of Metabolites
The absorbance and fluorescence excitation and emission spectra were taken for the characterized compounds. First, absorbance and fluorescence spectra of all compounds were measured at 5 mM concentrations in methanol. Based on the absorbance of the compounds, initial excitations were run using the absorbance values.
Compounds 1 and 7 were found to have similar excitation and emission spectra as L-kynurenine and were
found to have two excitation peaks (Figure 5). However, of the two excitation peaks, one was found to cause
a much stronger fluorescence emission. Peak absorbance of 1 and 7 was found to be 375 nm, whereas the
excitation spectra were found to be maximal at 407 and 374 nm, respectively. Emission spectra for 1 and 7
were found to be in the blue wavelength range at 447 nm (1) and 439 nm (7) (Figures 5A and 5G).
Compounds 2–5 and 6 were found to have similar excitation and emission spectra as L-tryptophan (Figure 5). Unlike 1 and 7, these compounds were only excited by one peak. Compounds 2, 4, and 5 were found
to emit in the blue wavelength with emissions close to 450 nm (453, 448, and 454 nm, respectively) and were
excited at 370 nm. Compound 3 was found to exhibit significantly red-shifted fluorescence than the other
compounds, which exhibited a blue wavelength emission peak of 477 nm with broad green spectrum
tailing. Similarly, compound 6 was found to have a blue wavelength emission, although it trailed into the
green spectra with a peak emission of 484 nm. Non-brominated kynurenine yellow is known to exhibit
bright green fluorescence with an emission maxima of 520 nm (Mizdrak et al., 2007; Zelentsova et al.,
2013), whereas our experimental fluorescence spectrum of bromo-kynurenine yellow (8) obtained in
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Figure 5. Absorbance and Fluorescence Emission of Shark Skin Metabolites
(A–H) Fluorescence Spectra of Pure Compounds 1–8 in methanol. See Figure S20 for spectra in PBS.

methanol revealed a blue wavelength emission maximum of 472 nm (Figure 5H). Given the discrepancy, we
further obtained fluorescence spectra of the compounds in a more biologically relevant phosphate buffered saline (PBS) system, and the compounds displayed significant shifts of their fluorescence spectra
compared with those in methanol (Table 1 and Figure S20). Specifically, the fluorescence emission spectrum of 8 exhibited a green emission maximum of 507 nm (Table 1 and Figure S20H). Consistent with kynurenine yellow, a large Stokes shift was observed in 8, which is known to be derived from a charge transfer
from the amino group to the carbonyl group in the kynurenine yellow scaffold (Zelentsova et al., 2013).
Thus, bromo-tryptophan-kynurenine metabolism products in an aqueous environment represent the
chemical source of bright green biofluorescence in shark skins.

Antibacterial Activities of the Metabolites
Collectively, we structurally characterized the previously undescribed chemical source of green-dominated
biofluorescence in the skin of both sharks (Figure 6). In the marine environment, C. ventriosum is benthic
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Methanol

PBS

Excitation Max (nm)

Emission Max (nm)

Excitation Max (nm)

Emission Max (nm)

Compound 1

407

447

414

451

Compound 2

370

453

401

481

Compound 3

323

477

NA

Compound 4

370

448

360

400

Compound 5

370

454

363

465

Compound 6

403

484

388

495

Compound 7

374

439

360

420

Compound 8

422

472

438

507

a

NAa

Table 1. Fluorescence of Compounds in Methanol and PBS
a
Not applicable due to low solubility.

(bottom-dwelling) and predominantly remains in direct contact with underwater sediment. Figures S21
and S22 show the demersal habitat of C. ventriosum from Scripps Canyon, California. As marine sediments
have higher concentrations of bacteria than the water column (Karl and Novitsky, 1988), we evaluated
the antibacterial activities of metabolites 1–7 against two bacterial pathogens, including a Grampositive methicillin-resistant Staphylococcus aureus (MRSA) and a Gram-negative Vibrio parahaemolyticus.
V. parahaemolyticus was chosen as a candidate as it is a common marine bacterium, often found in sediment. Major compound 4 found in both light and dark skin tissue samples exhibited a half-maximal inhibitory concentration (IC50) value of 66 mM against MRSA, and compound 3 showed growth inhibitory activity
against V. parahaemolyticus at an IC50 of 14 mM. The other metabolites showed no significant activity at
concentrations up to 100 mM (Figures S23 and S24). Based on these observations, the antibacterial properties of these biofluorescent metabolites may thus also contribute in part to chemical defense against microbial pathogens in the marine environment.

DISCUSSION
Although biofluorescence is a fascinating phenomenon that has been reported in an increasing diversity of
marine species in recent years, including sharks (Gruber et al., 2016; Sparks et al., 2014) and sea turtles
(Gruber and Sparks, 2015), its molecular origins remain largely unexplored. In this study, we describe a family of natural small molecule fluorophores that significantly contribute to shark skin biofluorescence. Interestingly, these small molecule metabolites represent a parallel bromo-tryptophan-kynurenine biosynthetic
pathway to that of the established tryptophan-kynurenine pathway widely found in vertebrates (Cervenka
et al., 2017). For example, kynurenine and its analogs regulate diverse human biological processes, and
accumulation of kynurenine in the brain is tightly associated with mental health disorders such as depression and schizophrenia (Cervenka et al., 2017). Of note, a halogenated kynurenine, L-4-chloro-kynurenine,
is a neuro-pharmaceutical prodrug of 7-chlorokynurenic acid, used to treat major depressive disorder (Vécsei et al., 2012). Although potential neurological activities of the brominated variant 1 and its analogs
remain an open question, it is intriguing to find brominated variants of mammalian signaling molecules
in shark skin. Although the exact source of the halogenase and its bromo-tryptophan product (whether
it be of shark, microbial symbiont, or environmental origin) remain unresolved, the observed diversity of
bromo-tryptophan catabolic processing in E. coli suggests that similarly flexible metabolic pathways
may also be at play in shark skin. As we observed differential regulation of these metabolites in light versus
dark skin, future studies aimed at assessing whether tryptophan-kynurenine metabolism genes are similarly
regulated, are warranted. Analogous to non-brominated kynurenine molecules functioning as UV radiation
filters in the human lens, these brominated kynurenine molecules could, in principle, complement melanin
pigments within shark skin to offer photo-protection from low-wavelength light (Sweet et al., 2012; Taylor
et al., 2002). Collectively, the discovery of brominated tryptophan-kynurenine metabolism products from
marine shark skins in our study not only illuminates the likely source of naturally occurring biofluorescence
of shark skins but also raises new questions regarding their potential roles in central nervous system
signaling, the resilience of shark skins to microbial infections, and diverse skin pigmentation phenotypes.
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Figure 6. Cross-Section of Sharks Showing Localization of Fluorescence in Skin Tissue
(A) Scyliorhinus retifer excited with 450–500 nm and imaged through 514nmLP, (B) cross section of skin with white light; (C)
fluorescence emission, (D) Cephaloscyllium ventriosum excited with 450–500 nm and imaged through 514nmLP, (E) cross
section of skin with white light, (F) fluorescence emission.

Limitations of the Study
A wide range of marine organisms are known to be biofluorescent, but the chemical ecological contributions to naturally occurring biofluorescence phenotypes has not been investigated at the detailed molecular level. As representative marine vertebrate animals, we focused on elucidating the bright green biofluorescence phenotype in swell sharks and in chain catsharks. A bromo-tryptophan precursor and a
bromo-diketopiperazine antibiotic were found in both skin types, whereas in light skin, the bromo-tryptophan precursor was processed through the kynurenine metabolic pathway, generating a collection of
brominated metabolites with varying spectral properties. Although we focused on the characterization
of small molecule sources involved in shark biofluorescence phenotypes in this study, underlying biosynthesis of these metabolites still remains to be explored. As aqueous sodium hydroxide was the solvent
used for extraction of shark skin materials in our system, we cannot rule out the possibility that the small
molecule fluorophores derive from base-catalyzed ester hydrolysis of currently uncharacterized parent
molecules. However, pure bromo-tryptophan as a standard solubilized under basic conditions and precipitated under acidic conditions (Figure S25), consistent with our small molecule findings.

METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.

SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.07.019.
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Transparent Methods
General
1H

and 2D (gCOSY, gHSQCAD, and gHMBCAD) NMR spectra were obtained from an

Agilent 600 MHz spectrometer with a cold probe (Agilent, Santa Clara, CA, USA) in methanol-d4
(Cambridge Isotope Laboratories, Inc. Tewksbury, MA, USA). High-resolution (HR) ESI-QTOFMS data were recorded using an Agilent iFunnel 6550 system with a Phenomenex Kinetex C 18
(100 Å) 5 μm (250 × 4.6 mm) column. For general HR-ESI-QTOF-MS analysis, extracts were
prepared by resuspension in 100 µl methanol (LC-MS grade, Fisher, USA). 2 µl of samples were
injected and analyzed at 25 ºC and 0.7 ml/min with a water:acetonitrile gradient solvent system
containing 0.1% formic acid: 0-30 min, 10-100% acetonitrile; hold for 5 min, 100% acetonitrile; 2
min, 100-10% acetonitrile; 5 min equilibration time 10% acetonitrile. Mass spectra were acquired
in the range of 25-1700 m/z in positive ion mode. Collected data was analyzed using Agilent
MassHunter Qualitative Analysis Software (Version B.06.00, Agilent Technologies), and all
targeted mass ions were extracted and analyzed within a 10 ppm error range [extracted ion count
(EIC) chromatograms]. Sep-Pak® Vac 35 cc (10 g) C18 cartridge (Waters Corporation, Milford,
MA) was used for the flash column chromatography. Reversed-Phase High-Performance Liquid
Chromatography (RP-HPLC) was performed on an Agilent Prepstar HPLC system. Two reversedphase columns, an Agilent Polaris C18-A 5 μm (250 × 21.2 mm) column and a Phenomenex Luna
C18(2) (100 Å) 10 μm (250 × 10.0 mm) column, were used for the separation and purification of
metabolites, respectively. Routine low-resolution HPLC-MS analysis was acquired by using an
Agilent 1260 Infinity Quaternary LC system with an autosampler and a photo diode array (PDA)
detector coupled to an Agilent 6120 single quadrupole Electrospray Ionization (ESI) mass
spectrometer.
Shark skin collection and extraction
Specimens of Cephaloscyllium ventriosum were obtained from Marinus Scientific, LLC.
This study was approved and carried out in strict accordance with the recommendations in the
Guidelines for the Use of Fishes in Research of the American Fisheries Society and the John B.
Pierce Laboratory’s Institutional Animal Care and Use Committee (IACUC) # VP5-2019. The
Scyliorhinus retifer skin used in this study was from Gruber et al (2016). A small fragment of the
fluorescent skin of each shark species was dissected and used for extraction studies. As the
fluorescent molecules are soluble in 0.1 M sodium hydroxide, samples of the shark were cut in 1
cm x 1 cm pieces and allowed to incubate in 0.1 M sodium hydroxide for 1 h before experiments
were conducted. Fluorescence spectra of shark skin extracts were recorded on a Hitachi F-7000
Fluorimeter.

Larger-scale extraction and isolation of metabolites
Crude materials from skin of the swell shark were extracted in a 0.1 M sodium hydroxide
solution, followed by subsequent extraction of the small molecule fraction with butanol. The small
molecules were fractionated by reversed-phase analytical HPLC system, eluting 30 HPLC
fractions using a Phenomenex Kinetex C18 (2) 5 µm column (250 × 4.6 mm) with a gradient of
0.01% trifluoroacetic acid in acetonitrile/water (Flow rate: 1 ml/min; 0-60 min, 10/90→100/0%, 1
min fraction window). HPLC fraction 12 was further subjected to reversed-phase HPLC [Column:
Phenomenex Luna C18 (100Å) 10 µm (250 × 4.6 mm)] with a linear gradient in acetonitrile/water
mobile phase elution (Flow rate: 1 ml/min; 0-60 min, 10/90→100/0%) to yield a 6-bromotryptophan (5) (tR = 10.5 min). The butanol-soluble fraction was subjected to a Sep-Pak® Vac 35
cc (10 g) C18 cartridge with a step gradient elution (20%, 40%, 60%, 80%, and 100% methanol in
water). The 80% methanol fraction was further fractionated using an Agilent Prepstar HPLC
system [Agilent Polaris C18-A 5 µm (250 × 21.2 mm) column] with a linear gradient elution (50100% acetonitrile in water over 60 min, 8 ml/min, 1 min fraction collection window). The HPLC
fraction 18 was purified on an Agilent Phenyl-Hexyl 5 µm (250 × 9.4 mm) column using a linear
gradient separation (50-100% acetonitrile in water, 2 ml/min) to yield 6-bromo-DKP (4) (tR = 10.1
min). The purified compounds were dried under reduced pressure on a Genevac HT-4X system
over 12 h for NMR analysis. All chemical structures of materials were fully characterized by LCMS co-injection with standards, 2D-NMR, and MS analysis.
Chemical synthesis of metabolites
6-Bromo-DL-tryptophan was purchased from Santa Cruz Biotechnology (Dallas, TX, USA).
To synthesize 8-bromo-DL-N-formyl-kynurenine, 6-bromo-DL-tryptophan (50 mg, 0.177 mmol, 1.0
eq) was added to a 10 ml round-bottom flask under air atmosphere. The chemical was suspended
in 2 ml water and meta-chloroperoxybenzoic acid (0.32 g, 1.854 mmol, 10.5 eq) was subsequently
added. The reaction was stirred at room temperature under air atmosphere for 20 h and
completion of the reaction was monitored by LC-MS analysis. Upon completion, the reaction was
transferred to a 20 ml scintillation vial using methanol and completely dried down using nitrogen
gas. The reaction material was fractionated on a Sep-Pak® Vac 35 cc (10 g) C18 cartridge with a
step gradient elution (20, 40, and 60% methanol in water). The 40% methanol fraction containing
8-bromo-DL-N-formyl-kynurenine (tR = 22.4 min, 3 mg) was then purified using a reversed-phase
HPLC with a Phenomenex Luna C18 (100Å) 10 µm column (250 × 4.6 mm) and a gradient of 20%
to 80% aqueous methanol for 30 min with a flow rate of 2 ml/min. For the deformylation, 8-bromoDL-N-formyl-kynurenine (2 mg, 0.006

mmol, 1.0 eq) was dissolved in a 1:1 mixture of trifluoroacetic

acid:water (600 μl). The reaction was stirred for 4 h at room temperature and dried using nitrogen

gas. The 8-bromo-DL-kynurenine (tR = 24.3 min, 2 mg) was then isolated on a Phenomenex Luna
C18 (100Å) 10 µm column (250 × 4.6 mm) at a flow rate of 2 ml/min with a linear gradient from
10%-80% over 30 min. Syntheses of enantiopure 8-bromo-L-N-formyl-kynurenine (2) and 8bromo-L-kynurenine (1) were conducted as above, but with using enantiopure 6-bromo-Ltryptophan (5) as starting material. For the deamination, 8-bromo-DL-kynurenine (2 mg) was
dissolved in anhydrous dimethylformamide (1 ml) and the reaction was initiated at 70 °C and
completed after 3 h. The reaction mixture was dried and was purified by reversed-phase HPLC
[Phenomenex Luna C18 (100Å) 10 µm column (250 × 4.6 mm), 2 ml/min] with a linear gradient of
10% acetonitrile/0.1% formic acid-100% acetonitrile/0.1% formic acid in water over 60 min with a
flow rate of 2 ml/min to yield 8-bromo-CKA (carboxyketoalkene) (3) (tR = 36.1 min, 0.6 mg).
For the chemical synthesis of compound 8, 7-bromoquinoline-2-carboxylic acid (8a) was
purchased from Millipore Sigma (St. Louis, MO, USA). Compound 8a (200 mg) was suspended
in a solvent mixture (acetone/water = 10:1). Methyl iodide (300 μl) and potassium carbonate (600
mg) were added and refluxed for 2 h. The reaction mixture was dried and extracted with ethyl
acetate to yield 8b (~200 mg). Reduction of 8b in glacial acetic acid (5 ml) was performed utilizing
sodium cyanoborohydride (150 mg) at 25 °C for 3 h. The reaction mixture was neutralized with
saturated sodium bicarbonate followed by the ethyl acetate extraction twice. The crude reaction
materials were directly treated with acetic anhydride (8 ml) and heated at 90 °C for 3 h and was
separated by reversed-phase HPLC [Phenomenex Luna C18 (100Å) 10 µm column (250 × 4.6
mm), 2 ml/min] with a linear gradient of 20% acetonitrile/0.1% formic acid-60% acetonitrile/0.1%
formic acid in water for 30 min with a flow rate of 2 ml/min to yield 8d (tR = 16.2 min, 110 mg). The
benzylic oxidation on 8d (80 mg) was initiated with chromium hexacarbonyl (50 mg) and tert-butyl
hydroperoxide (70 wt% in water, 600 μl) in acetonitrile and refluxed for 24 h. The product 8e was
eluted at tR = 16.5 min under the aforementioned purification condition for 8d. The deprotection
of 8e (15 mg) was achieved in water containing potassium carbonate (20 mg) and refluxed for 2
h, yielding 8 (13 mg).
Biotransformation of 6-bromo-tryptophan to 8-bromo-kynurenine in E. coli
E. coli Nissle 1917 (EcN) colonies were used to inoculate 5 ml of lysogeny broth (LB) (BD,
Franklin Lakes, NJ, USA; 1% (w/v) tryptone, 0.5% (w/v) yeast extract, and 1% (w/v) sodium
chloride) for a total of three biological replicates and incubated at 37 °C with shaking at 250 rpm
for 16 h. After overnight, 20 μl of each seed culture was used to inoculate 2 ml of M9 minimal
medium (VWR Funding Inc., West Chester, PA, USA; 0.6% (w/v) Na2HPO4, 0.3% (w/v) KH2PO4,
0.05% (w/v) NaCl, 0.1% (w/v) NH4Cl, 0.2% (w/v) glucose, 2 mM MgSO4, and 0.1 mM CaCl2)

supplemented with 10 mM 6-bromo-D-tryptophan, 10 mM 6-bromo-L-tryptophan, 1 mM 6-bromoD-tryptophan,

1 mM 6-bromo-L-tryptophan, or nothing (negative control). The inoculated cultures

were grown at 37 °C with shaking at 250 rpm. After 20 h cultivation, each culture was extracted
with 3 ml butanol, vortexed, and centrifuged. The organic layers were dried and resuspended in
80 μl methanol for LC-MS analysis. These experiments were performed with biological triplicates.
Addition of the amino acids required solubilization in 1N sodium hydroxide, followed by
neutralization with 1N hydrochloric acid.
Fluorescence spectra
Fluorescence spectra from all compounds 1-8 were measured at a concentration of 5 mM
in methanol on a Hitachi-F-7000 Spectrophotometer.
In situ and microscope fluorescence imaging
To excite a fluorescence response of the sharks, a Aquatica Rouge underwater housing
was fitted with custom designed blue excitation lighting. The LED light (Royal Blue) was collimated
to ensure its perpendicular incidence on the scientific grade 450/70 nm interference filter surface
(Semrock, Inc., Lake Forest, IL), minimizing the transmission of out-of-band energy. The ultrabright LEDs, collimating lenses, filters, and exit diffusers were contained in custom-made waterand pressure-proof housings and powered by NiMH Battery Packs (Ikelite Underwater Systems,
Indianapolis, IN). To image and record biofluorescence, a scientific-grade 514 nm long-pass
emission filter (Semrock, Inc.) was placed in front of the sensor of the camera. Cross-sections of
both sharks were taken on an AxioZoom v16 stereo fluorescent microscope using a PlanNeoFluar
Z 2.3×/0.57 objective and 38 HE GFP filter set.
Marfey’s analysis for absolute configuration determination
Dried 6-bromo-DKP (diketopiperazine) (4) (~0.1 mg) was acid-hydrolyzed in 1 N
hydrochloric acid (250 μl) at 110 °C for 1 h with stirring. After cooling down, the hydrolysate was
dried under the purge of nitrogen gas. The standards

D-

and

L-6-bromo-tryptophan

were

purchased from LabNetwork, Inc. (South Portland, ME, USA). The standards D- and L-8-bromokynurenines and 8-bromo-N-formyl-kynurenines were prepared as described in the chemical
synthesis section. The dried hydrolysates, naturally-purified compounds, and commercial
standards, were treated with 25 μl of a solution of Nα-(2,4-dinitro-5-fluorophenyl)-L-alaninamide
(FDAA) (10 mg/ml in acetone) followed by the addition of 100 μl of 1 N sodium bicarbonate to
yield L-FDAA derivatized compounds. The reactions were heated at 80 °C for 3 min and
neutralized with 25 μl of 2 N hydrochloric acid. The Marfey’s derivatives were then diluted to 20100 μl methanol for single quadrouple LC-MS and/or HR-ESI-QTOF-MS analysis. 2-10 μl

samples were analyzed using a Phenomenex Kinetex C18 (100Å) 5 μm (250 × 4.6 mm) column
with a flow rate (0.7 ml/min) and a solvent system of water and acetonitrile containing 0.1% formic
acid (v/v). The retention times of L-FDAA derivatized compounds were determined as follows: a
linear gradient elution with 50-100% acetonitrile, 6.2 min for L-FDAA derivatized 6-bromo- Ltryptophan, 6.8 min for L-FDAA derivatized 6-bromo-D-tryptophan, 6.5 min for L-FDAA derivatized
8-bromo- L-kynurenine, and 7.1 min for L-FDAA derivatized 8-bromo-D-kynurenine.
Antibacterial activity of metabolites
Antibacterial activities of metabolites were evaluated using the minimum inhibitory
concentration (MIC) assay in 96-well plates. Stock solutions of metabolites were prepared in
sterile dimethyl sulfoxide with a concentration of 10 mM. Dimethyl sulfoxide was used as a
negative control, and chloramphenicol was prepared as positive control for the antibacterial
activity against methicillin-resistant Staphylococcus aureus (MRSA) and Vibrio parahaemolyticus.
The stock solutions of compounds (10 mM) were serially diluted and adjusted to ten different final
concentrations (100, 50, 25, 12.5, 6.25, 3.13, 1.56, 0.78, 0.39, and 0.19 μM) in the same
concentration of fresh dimethyl sulfoxide. MRSA was grown in tryptic soy broth (TSB) and V.
parahaemolyticus was grown in Marine Broth. Media (50 μl) containing compound at the varying
concentrations was added to each well. Overnight cultures of the bacteria were diluted to OD 600
= 0.05, 50 μl of the cell culture broth was then dispensed into individual wells, and the plates were
sealed and incubated at 37 °C overnight. Plates were then read for OD600 using a PerkinElmer
Envision 2100 multimode plate reader (PerkinElmer, Waltham, MA, USA). All samples were
tested in triplicate.

Figure S1. HR-ESI-QTOF-MS spectra of metabolites 1-8. Related to Figure 2.

Figure S2. HPLC chromatogram of crude extract from the skin of C. ventriosum. The 10 mg of
crude samples were dissolved in 100 μl methanol and 10 μl of samples were analyzed for HPLCMS analysis. This figure shows the two major metabolites, 4 and 5 (210 and 254 nm spectra are
shown). Related to Figure 2.

Figure S3. Synthetic scheme of metabolites 1-3 (A) and 8 (B). Related to Figure 2.

Figure S4. Structural characterization of 1. (A) UV-visible spectrum of purified 1. (B) Key 2D NMR
(COSY and HMBC) correlations of 1. (C) Co-injection studies using skin extract and standard 1.
(D) Marfey’s analysis. Related to Figure 2.

Figure S5. Structural characterization of 2. (A) UV-visible spectrum of purified 2. (B) Key 2D NMR
(COSY and HMBC) correlations of 2. (C) Co-injection with skin extract and standard 2. (D)
Marfey’s analysis. Related to Figure 2.

Figure S6. Structural characterization of 3. (A) UV-visible spectrum of purified 3. (B) Key 2D NMR
(COSY and HMBC) correlations of 3. (C) Co-injection with skin extract and standard 3. Related
to Figure 2.

Figure S7. Structural characterization of 4. (A) UV-visible spectrum of purified 4. (B) Key 2D NMR
(COSY and HMBC) correlations of 4. (C) Marfey’s analysis. Related to Figure 2.

Figure S8. Structural characterization of 5. (A) UV-visible spectrum of purified 5. (B) Key 2D NMR
(COSY and HMBC) correlations of 5. (C) Marfey’s analysis. Related to Figure 2.

Figure S9. Structural characterization of 6. (A) UV-visible spectrum of 6. (B) Chemical structure
of 6. (C) Co-injection with skin extract and standard 6. Related to Figure 2.

Figure S10. Structural characterization of 7. (A) UV-visible spectrum of 7. (B) Chemical structure
of 7. (C) Co-injection with skin extract and standard 7. Related to Figure 2.

Figure S11. Structural characterization of 8. (A) UV-visible spectrum of 8. (B) Key 2D NMR
(COSY and HMBC) correlations of 8. (C) Co-injection with skin extract and standard 8. Related
to Figure 2.

Figure S12. NMR spectra of 1. Related to Figure 2.

Figure S13. NMR spectra of 2. Related to Figure 2.

Figure S14. NMR spectra of 3. Related to Figure 2.

Figure S15. NMR spectra of 4. Related to Figure 2.

Figure S16. NMR spectra of 5. Related to Figure 2.

Figure S17. NMR spectra of 8. Related to Figure 2.

Figure S18. NMR spectra of synthetic intermediates 8b (A), 8d (B), and 8e (C). Related to
Figure 2.

Figure S19. HPLC-MS analysis for the production of 8-bromo-kynurenine (1) from E. coli culture
in the presence and absence of 6-bromo-tryptophan. Related to Figure 4.

Figure S20. Excitation and emission spectra of compounds 1-8 in Phosphate Buffered Saline
(PBS). Related to Figure 5.

Figure S21. Cephaloscyllium ventriosum imagined in their natural habitat in the eastern Pacific,
demonstrating their sedentary bottom-dwelling nature. Related to Figure 6.

Figure S22. Fluorescent imaging camera system used for Cephaloscyllium ventriosum in its
natural habitat in the eastern Pacific (30 m, Scripps Canyon, CA). Related to Figure 6.

Figure S23. Growth inhibitory assay of metabolites against methicillin-resistant S. aureus
(MRSA). Related to Figure 6.

Figure S24. Growth inhibitory assay of metabolites against Vibrio parahaemolyticus. Related to
Figure 6.

Figure S25. Solubility of 6-bromo-L-tryptophan in varying solvents. Figure shows fluorescence
image of 6-bromo-L-tryptophan from typhoon instrument with a scanning progress of Alexa Fluor
488. Related to Figure 4.

Table S1. HR-ESI-QTOF-MS data of metabolites 1-8. Related to Figure 2.
No Obsd.
Calcd.
Chemical
formula
+
+
+
+
+
+
[M]
[M+2]
[M+4]
[M]
[M+2]
[M+4]
1
287.0032 289.0013
287.0031 289.0011
C10H11BrN2O3
2
314.9991 316.9971
314.9980 316.9960
C11H11BrN2O4
3
269.9777 271.9758
269.9766 271.9745
C10H9BrNO3
4
528.9875 530.9859 532.9843 528.9875 530.9854 532.9834 C22H18Br2N4O2
5
283.0109 285.0090
283.0082 285.0062
C11H11BrN2O2
6
267.9605 269.9584
267.9609 269.9589
C10H6BrNO3
7
215.9667 217.9647
215.9660 217.9640
C7H6BrNO2
8
269.9748 271.9731
269.9766 271.9745
C10H9BrNO3

Table S2. NMR assignments of compounds 1-3 in MeOD. Related to Figure 2.
Compound 1
Compound 2
Compound 3
δH mult
δH mult
δH mult
No
δC
δC
(J, Hz)
(J, Hz)
(J, Hz)
1
172.0 C
172.0 C
170.6
4.01 dd
4.01 dd
6.76 d
135.7
2
50.4
CH
50.2
CH
(9.0, 2.9)
(8.5, 3.3)
(15.4)
3.66 dd
3.75 dd
7.76 d
134.5
3
(18.5,
39.0
CH2 (18.6,
39.9
CH2 (15.4)
2.9)
3.3)
3.48 dd
3.57 dd
(18.5,
(18.6,
9.0)
8.5)
4
198.1 C
200.7 C
191.1
5
115.0 C
121.2 C
116.2
7.63 d
7.95 d
7.69 d
132.8
6
132.2 CH
132.2 CH
(8.7)
(8.5)
(8.7)
6.72 dd
118.0
6.70 dd
7.42 dd
7
117.8 CH
126.4 CH (8.7,
(8.7, 2.0)
(8.5, 2.0)
1.9)
8
129.2 C
129.2 C
129.2
6.96 d
6.97 d
119.0
9
119.0 CH 8.85 brs
124.0 CH
(2.0)
(1.9)
10
152.5 C
139.8 C
153.1
N-formyl
8.43 brs
161.1 CH

C
C
H
C
H

C
C
C
H
C
H
C
C
H
C

Table S3. NMR assignments of compounds 4 and 5 in MeOD. Related to Figure 2.
Compound 4
Compound 5
Position δH mult (J, Hz)
δC
Position δH mult (J, Hz)
δC
1, 1ʹ
NH 1
2, 2ʹ
6.60 s
125.1 CH 2
7.18 s
124.6
3, 3ʹ
108.7 C
3
108.7
3a, 3aʹ
126.2 C
3a
126.1
4, 4ʹ
7.26 d (8.5)
119.8 CH 4
7.60 d (8.4)
119.5
7.12 dd (8.5,
7.14 dd (8.5,
5, 5ʹ
121.9 CH 5
121.8
1.7)
1.7)
6, 6ʹ
114.6 C
6
114.7
7, 7ʹ
7.47 d (1.7)
113.8 CH 7
7.51 d (1.6)
113.9
7a, 7aʹ
137.4 C
7a
137.8
2.89 dd (14.5,
3.44 dd (15.3,
8, 8ʹ
29.8
CH2 8
27.0
3.8)
4.2)
2.18 dd (14.5,
3.14 dd (15.3,
7.1)
9.0)
4.04 dd (7.0,
3.81 dd (9.0,
9, 9ʹ
55.6
CH 9
55.3
3.9)
4.2)
10, 10ʹ
168.1 C
10
172.8

NH
CH
C
C
CH
CH
C
CH
C
CH2

CH
C

Table S4. NMR assignments of compound 8 in MeOD. Related to Figure 2.
Compound 8
No
δH mult (J, Hz)
δC
1
173.0
C
2
4.32 m
54.0
CH
3
2.93 dd (16.5, 6.0)
39.1
CH2
2.85 dd (16.5, 7.5)
4
192.3
C
5
116.8
C
6
7.54 d (8.5)
128.0
CH
7
6.78 dd (8.5, 1.5)
120.2
CH
8
130.1
C
9
7.07 d (1.5)
118.4
CH
10
152.4
C

Video S1. Footage of Cephaloscyllium ventriosum. Related to Figure 1.
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